Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,956,259 Pharmaceutical composition for preventing and treating obesity, containing green-tea see husk extract as active...
The present invention relates to a pharmaceutical composition for preventing and treating obesity which comprises the green tea (Camellia sinensis L.) seed husk...
US-9,956,258 Transfer factor preparations and associated methods
A drink includes an edible liquid or semisolid preparation and transfer factor. The drink may also include lactoferrin and one or more preservatives. An edible...
US-9,956,257 Canola extracts containing high levels of phenolic acids
Disclosed in certain embodiments is a canola extract comprising greater than 30% sinapic acid, pharmaceutical compositions thereof, and methods thereof.
US-9,956,256 Bacteriophage and composition comprising same
The present invention relates to a novel bacteriophage .PHI.CJ26 (KCCM11464P) and a composition comprising the same as an active ingredient. In addition, the...
US-9,956,255 Method to reduce body weight, fat accumulation and adipocyte size using Parabacteroides goldsteinii
The present invention describes a method to reduce body weight, fat accumulation and adipocyte size by administering the probiotic bacterium Parabacteroides...
US-9,956,254 Extract of taiwanese propolis for treating ocular diseases
The present invention provides a method for treating an ocular disease in a subject in need thereof, comprising administering an effective amount of an extract...
US-9,956,253 Placental tissue grafts
A method for preparing placenta membrane tissue grafts for medical use, includes obtaining a placenta from a subject, cleaning the placenta, separating the...
US-9,956,252 Purified amniotic membrane compositions and methods of use
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating...
US-9,956,251 Preparation method for therapeutic agent of bead-type chondrocyte
The present invention relates to a preparation method for a therapeutic agent of a bead-type chondrocyte and, more specifically, to: a preparation method for a...
US-9,956,250 Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or...
Provided are uses of allogeneic interstitial vessel-layer cells and allogeneic mesenchymal progenitor cells in the preparation of a pharmaceutical composition...
US-9,956,249 Compositions and methods for expansion of embryonic hematopoietic stem cells
The present invention relates to methods, kits and compositions for expansion of embryonic hematopoietic stem cells and providing hematopoietic function to...
US-9,956,248 Methods of manufacture of therapeutic products comprising vitalized placental dispersions
This invention provides a fluid therapeutic placental product comprising placental cells and a placental dispersion comprising placental factors. The placental...
US-9,956,247 Method of treating lysosomal storage diseases
Nucleases and methods of using these nucleases for inserting a sequence encoding a therapeutic protein such as an enzyme into a cell, thereby providing proteins...
US-9,956,246 Solid ingestible composition comprising a fat globule membrane component and water-soluble dietary fiber
A solid composition comprising the following components (A) and (B): (A) from 20 to 65 mass % of a fat globule membrane component; and (B) from 0.2 to 4 mass %...
US-9,956,245 Glucan compositions
The present invention relates to a gel composition comprising a glucan and a gelling agent, said composition having a melting point (gel to sol) above...
US-9,956,244 Biomarker Hsp90 for predicting effect of a c-Met inhibitor
A biomarker Hsp90 for predicting an efficacy of a c-Met inhibitor, selecting a subject for application of a c-Met inhibitor, or monitoring an efficacy of a...
US-9,956,243 Combination treatment for acute myeloid leukemia (AML)
The present invention relates to a pharmaceutical product comprising a) as a first component an inhibitor of the MDM2-p53 interaction such as, for example: ...
US-9,956,242 Pharmaceutical composition for prevention or treatment of cognitive function disorders comprising spinosin
The pharmaceutical composition of the present invention, which comprises spinosin or a spinosin-containing herbal extract, is a composition for preventing and...
US-9,956,241 Application of American Ginseng to enhance neurocognitive function
Disclosed are methods of enhancing neurocognitive function by administering of American Ginseng. Preferred dosages in the range of 5 to 50 mg total ginsenosides...
US-9,956,240 Therapeutic monosaccharide-based inhibitors of hexokinase and glucokinase for parasitic diseases, along with...
Methods for treating a mammal that is infected by a parasitic organism are provided, along with pharmaceutical compositions and compounds. The method includes...
US-9,956,239 Methods of treating retroviral infections and related dosage regimes
The present invention relates to compounds and methods for treating retroviral infections and/or Hepatitis B viral infections. Some compounds of the invention...
US-9,956,238 Compositions for administration of zoledronic acid or related compounds for treating low back pain
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions,...
US-9,956,237 Osteoclast inhibitors for knee conditions
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions,...
US-9,956,236 Methods for increasing immune responses using agents that directly bind to and activate IRE-1
The invention provides, e.g., compositions and methods for increasing activation of immune cells.
US-9,956,235 Reducing the reproductive capacity of mammals
Provided are compositions and methods for reducing the reproductive capacity of mammals. The compositions and methods involve the use and administration of (a)...
US-9,956,234 Osteoclast inhibitors for joint conditions
Oral dosage forms of osteoclast inhibitors, such as neridronic acid and zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or...
US-9,956,233 Neuroprotection by mitochondria-targeted metformin
The present invention provides modified metformin compounds, particularly mito-metformin compounds, and pharmaceutical compositions thereof. Methods of using...
US-9,956,232 Dialkyl-phosphinoyl-alkane (Dapa) compounds and compositions for treatment of lower gastrointestinal tract...
Heat abstraction from the body's surfaces causes sensations of cold from the skin, orbit, nose, mouth, throat, upper esophagus, airways, and anogenital...
US-9,956,231 Topical formulations comprising a steroid
The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are...
US-9,956,230 Method for visual enhancement and post procedure treatment protocol
A new and novel method for determining post procedural treatment is disclosed herein. In one embodiment, a method for a treating a patient following a surgical...
US-9,956,229 Acyclic cucurbit[n]uril type molecular containers to treat intoxication and decrease relapse rate in substance...
Provided are methods for reversing the effects of drugs of abuse. The method involves administering acyclic CB[n]-type compounds to a mammal in need of the...
US-9,956,228 Method of treating acute myeloid leukemia and/or acute lymphoblastic leukemia using thienotriazolodiazepine...
A method of treating acute myeloid leukemia, acute lymphoblastic leukemia, high risk myelodysplastic syndrome, and/or HR-MDS/AML in a mammal by administering a...
US-9,956,227 Method for the treatment of residual symptoms of schizophrenia
The disclosure provides the use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals for the treatment of residual symptoms...
US-9,956,226 Methods and compounds for the inhibition of cellular proliferation
Methods for inhibiting translation, treating a cellular proliferative disorder, and inhibiting proliferation of cells using the compounds disclosed herein are...
US-9,956,225 Treatment of myelodysplastic syndrome
The present invention relates to the use of Volasertib or a pharmaceutically acceptable salt thereof or the hydrate thereof for treating myelodysplastic...
US-9,956,224 Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones
Described herein are compounds of Formula I and Formula II, methods of their synthesis, compositions comprising the compounds, and use of the compounds and...
US-9,956,223 Screening method
The invention discloses a screening method for the identification of new compounds for use in the treatment of cancer.
US-9,956,222 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
The invention relates to a quinazoline derivative represented by the general formula (I), a pharmaceutical acceptable salt and a stereoisomer thereof as...
US-9,956,221 Use of a receptor-type kinase modulator for treating polycystic kidney disease
The invention comprises a method of treating polycystic kidney disease (PKD) in a mammal, such as a human or feline (e.g., Persian cat), comprising...
US-9,956,220 Imidazo-pyridazine derivatives as casein kinase 1 .delta./ inhibitors
The invention provides compounds of Formula (I) and pharmaceutically-acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity...
US-9,956,218 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
US-9,956,217 Treatment of joint conditions
The invention provides a method of treating a joint condition. The method comprises administering a multi-dose regimen of a pharmaceutical composition...
US-9,956,216 Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
US-9,956,215 Methods of treating cancer with farnesyltransferase inhibitors
The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma...
US-9,956,214 5-aminopyrazole-4-carboxamide inhibitors of CDPK1 from T. gondii and C. parvum
The present disclosure is generally directed to compositions and methods for treating apicomplexan protozoan related disease, such as toxoplasmosis and...
US-9,956,213 Substituted naphthyridine and quinoline compounds as MAO inhibitors
The invention provides a chemical entity of Formula (I) ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, Y, and n have any of the values described herein and...
US-9,956,212 Quinoline carboxamides for use in the treatment of multiple myeloma
A compound of formula (I), or a pharmaceutically acceptable salt thereof, for use in the treatment of multiple myeloma. ##STR00001##
US-9,956,211 Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the...
The present invention relates to compositions comprising a lipophilic local anaesthetic, preferably bupivacaine or a pharmaceutically active salt thereof, which...
US-9,956,210 Enhancer of zeste homolog 2 inhibitors
This invention relates to novel substituted benzamide according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical...
US-9,956,209 Compounds .alpha..sub.v .beta..sub.6 integrin antagonists
A compound of formula (I): ##STR00001## which is 4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolid- ...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.